KLRS Q3 2023 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena

KLRSKalaris Therapeutics Inc

$187M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$4M

Operating Income

-$47M

Net Income

-$44M

EPS (Diluted)

$-8.94

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$248M

Total Liabilities

$53M

Stockholders' Equity

$195M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$4M	-$199,000	-1730.7%
Operating Income	-$47M	-$43M	-9.3%
Net Income	-$44M	-$42M	-5.2%